Select Medical Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Select Medical Holdings wird ein jährliches Gewinn- und Umsatzwachstum von 27.7% bzw. 4.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich sinken um 1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.1% betragen.

Wichtige Informationen

10.5%

Wachstumsrate der Gewinne

3.2%

EPS-Wachstumsrate

Healthcare Gewinnwachstum	19.3%
Wachstumsrate der Einnahmen	4.5%
Zukünftige Eigenkapitalrendite	9.8%
Analystenabdeckung	Low
Zuletzt aktualisiert	21 Aug 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

May 05

Recent updates

Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125

Aug 05

Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher

Jul 19

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Jul 01

Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

Jun 13

There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price

May 26

Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

May 05

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Apr 19

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Apr 11

Select Medical: Solid Growth Prospects And A Compelling Valuation

Mar 05

Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

Feb 18

Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors

Oct 25

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Oct 04

Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Sep 16

Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold

Aug 11

Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Aug 07

Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

Jul 14

At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?

Jun 29

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

May 27

Select Medical: Revising To Hold As Business Economics Roll Lower

May 26

Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital

Apr 05

Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?

Mar 17

Select Medical GAAP EPS of $0.22 misses by $0.11, revenue of $1.58B in-line

Feb 23

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

Jan 31

The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence

Dec 20

Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?

Dec 01

Select Medical declares $0.125 dividend

Nov 03

These 4 Measures Indicate That Select Medical Holdings (NYSE:SEM) Is Using Debt Extensively

Nov 01

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Sep 16

Select Medical: Adding To Position For Further Upside Capture

Sep 14

Gewinn- und Umsatzwachstumsprognosen

NYSE:SEM - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	7,707	315	N/A	N/A	2
12/31/2025	7,331	380	N/A	N/A	5
12/31/2024	7,027	360	N/A	N/A	5
6/30/2024	6,873	259	288	507	N/A
3/31/2024	6,788	260	241	464	N/A
12/31/2023	6,664	235	353	582	N/A
9/30/2023	6,587	217	191	415	N/A
6/30/2023	6,489	196	177	393	N/A
3/31/2023	6,399	174	128	330	N/A
12/31/2022	6,334	153	94	285	N/A
9/30/2022	6,312	175	21	212	N/A
6/30/2022	6,278	223	19	216	N/A
3/31/2022	6,258	329	-20	168	N/A
12/31/2021	6,205	389	221	401	N/A
9/30/2021	6,105	415	503	669	N/A
6/30/2021	5,995	415	553	705	N/A
3/31/2021	5,664	306	1,077	1,224	N/A
12/31/2020	5,532	250	882	1,028	N/A
9/30/2020	5,446	206	860	999	N/A
6/30/2020	5,415	162	859	998	N/A
3/31/2020	5,544	155	300	448	N/A
12/31/2019	5,454	143	288	445	N/A
9/30/2019	5,344	136	210	380	N/A
6/30/2019	5,218	138	235	410	N/A
3/31/2019	5,153	140	308	485	N/A
12/31/2018	5,081	133	327	494	N/A
9/30/2018	4,911	207	309	489	N/A
6/30/2018	4,720	193	205	415	N/A
3/31/2018	4,527	189	N/A	345	N/A
12/31/2017	4,365	171	N/A	238	N/A
9/30/2017	4,300	93	N/A	196	N/A
6/30/2017	4,259	82	N/A	209	N/A
3/31/2017	4,237	74	N/A	180	N/A
12/31/2016	4,217	112	N/A	347	N/A
9/30/2016	4,211	121	N/A	286	N/A
6/30/2016	4,178	143	N/A	312	N/A
3/31/2016	3,973	146	N/A	282	N/A
12/31/2015	3,683	127	N/A	208	N/A
9/30/2015	3,420	123	N/A	222	N/A
6/30/2015	3,165	121	N/A	204	N/A
3/31/2015	3,052	119	N/A	224	N/A
12/31/2014	3,020	117	N/A	171	N/A
9/30/2014	2,997	121	N/A	230	N/A
6/30/2014	2,963	118	N/A	213	N/A
3/31/2014	2,949	111	N/A	188	N/A
12/31/2013	2,938	112	N/A	193	N/A
9/30/2013	2,936	122	N/A	220	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: SEMDas prognostizierte Gewinnwachstum (27.7% pro Jahr) liegt über der Sparquote (2.5%).

Ertrag vs. Markt: SEMDie Erträge des Unternehmens (10.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (15.2% pro Jahr).

Hohe Wachstumserträge: SEMDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: SEMDie Einnahmen des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).

Hohe Wachstumseinnahmen: SEMDie Einnahmen des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: SEMDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (15.7%).

Select Medical Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target increased by 8.9% to US$39.00

Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

Select Medical Reaffirms Earnings Guidance for the Year 2024

Price target increased by 7.5% to US$35.80

Select Medical Holdings Corporation Provides Earnings Guidance for the Second Quarter Ended June 30, 2023

Price target increased by 7.8% to US$35.80

Recent updates

Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125

Second quarter dividend of US$0.13 announced

Second quarter 2024 earnings: EPS misses analyst expectations

Select Medical Holdings Corporation Declares a Cash Dividend, Payable on or About August 30, 2024

Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Select Medical Holdings Corporation to Report Q2, 2024 Results on Aug 01, 2024

Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price

Price target increased by 8.9% to US$39.00

Investor sentiment improves as stock rises 17%

First quarter dividend of US$0.13 announced

Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

New minor risk - Shareholder dilution

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Select Medical Reaffirms Earnings Guidance for the Year 2024

Insufficient new directors

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings Corporation to Report Q1, 2024 Results on May 02, 2024

Select Medical Holdings Corporation, Annual General Meeting, Apr 25, 2024

Co-Founder & Executive Chairman notifies of intention to sell stock

Price target increased by 7.5% to US$35.80

Select Medical: Solid Growth Prospects And A Compelling Valuation

Fourth quarter dividend of US$0.13 announced

Full year 2023 earnings: EPS misses analyst expectations

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About March 13, 2024

Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings Corporation to Report Q4, 2023 Results on Feb 22, 2024

We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt

Co-Founder & Executive Chairman notifies of intention to sell stock

Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes

Co-Founder & Executive Chairman notifies of intention to sell stock

Upcoming dividend of US$0.13 per share at 2.3% yield

Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About November 28, 2023

Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors

Select Medical Holdings Corporation to Report Q3, 2023 Results on Nov 02, 2023

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings Corporation Announces Appointment of Michael Malatesta as Chief Financial Officer, Effective October 1, 2023

Select Medical Holdings Corporation Announces Appointment of Michael Malatesta as Chief Financial Officer, Effective October 1, 2023

Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Second quarter 2023 earnings: EPS exceeds analyst expectations

Select Medical Holdings Corporation Announces Cash Dividend, Payable on or about September 1, 2023

Select Medical Holdings Corporation Provides Earnings Guidance for the Second Quarter Ended June 30, 2023

Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings Corporation to Report Q2, 2023 Results on Aug 03, 2023

Co-Founder & Executive Chairman notifies of intention to sell stock

At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?

Select Medical Holdings Corporation(NYSE:SEM) dropped from Russell Small Cap Comp Value Index

Co-Founder & Executive Chairman notifies of intention to sell stock

Co-Founder & Executive Chairman notifies of intention to sell stock

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

Select Medical: Revising To Hold As Business Economics Roll Lower

Co-Founder & Executive Chairman notifies of intention to sell stock

Insider recently sold US$296k worth of stock

Upcoming dividend of US$0.13 per share at 1.7% yield

Price target increased by 7.8% to US$35.80

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Select Medical Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of 2023

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About May 31, 2023